Education > XRAY > Search Results

FORCE's eXaming the Relevance of Articles for You (XRAY) program looks behind the headlines of cancer news to help you understand what the research means for you. XRAY is a reliable source of hereditary cancer research-related news and information.
Learn more about the XRAY program

61 through 70 of 212

Relevance: High

pointerRelevance

Strength of Science: High

pointerStrength of Science

Research Timeline: Post Approval

pointerResearch Timeline
View Related Clinical Trials

Study : New targeted therapy approved for early-stage HER2-positive breast cancer

Most relevant for: People with early-stage, Her2-positive breast cancer (stages 1-3)

The KATHERINE trial looked at the benefit of the new drug, Kadcyla, for treating early-stage breast cancer after surgery and chemotherapy. The results of this study led to FDA approval in May 2019. (6/17/19)

Read More
New targeted therapy approved for early-stage HER2-positive breast cancer

Relevance: Medium-High

pointerRelevance

Strength of Science: High

pointerStrength of Science

Study : A low-fat diet may decrease postmenopausal breast cancer deaths

Most relevant for: Post-menopausal women with no breast cancer diagnosis

Research reported at the 2019 annual meeting of the American Society of Clinical Oncology establishes a link between dietary fat intake and its impact on postmenopausal women’s risk of dying from breast cancer. (6/13/19)

Read More
A low-fat diet may decrease postmenopausal breast cancer deaths

Relevance: Medium-High

pointerRelevance

Quality of Writing: Medium-High

pointerQuality of Writing

Personal Story : A young woman's story of genetic testing and risk-reducing mastectomy

Most relevant for: Young women of color with a BRCA mutation

Alejandra Campoverdi comes from a family with three generations of breast cancer. As a former White House aide and active educator in the Latina community, she has openly shared her story of genetic testing, her BRCA2 mutation and her plans for risk-reducing mastectomy at age 39. (6/6/19)

Este artículo está disponible en español.

Read More
A young woman's story of genetic testing and risk-reducing mastectomy

Relevance: High

pointerRelevance

Research Timeline: Post Approval

pointerResearch Timeline
View Related Clinical Trials

Guideline : FDA approves an immunotherapy treatment for some patients with triple-negative breast cancer

Most relevant for: People with metastatic, triple-negative breast cancer

The FDA approved the use of the immunotherapy drug atezolizumab (Tecentriq) in combination with the chemotherapy agent nab-paclitaxel (Abraxane) for certain patients with advanced triple-negative breast cancer. (5/26/19)

Read More
FDA approves an immunotherapy treatment for some patients with triple-negative breast cancer

Relevance: Medium-High

pointerRelevance

Strength of Science: Medium-High

pointerStrength of Science

Study : Do Vitamin B supplements alter breast cancer risk for women with BRCA mutations?

Most relevant for: High risk women with a BRCA1 mutation

Vitamins are an essential part of our diet. Vitamin supplements are often used to improve general health. This study explores how vitamin B supplements may affect breast cancer risk in women with BRCA mutations. (5/17/19)

Read More
 Do Vitamin B supplements alter breast cancer risk for women with BRCA mutations?

Relevance: Medium-High

pointerRelevance

Strength of Science: Medium-High

pointerStrength of Science

Research Timeline: Human Research

pointerResearch Timeline
View Related Clinical Trials

Study : Smart drug shows promising results for treatment of metastatic triple-negative breast cancer

Most relevant for: People with metastatic, triple-negative breast cancer

We report results of an early-stage clinical trial of a new class of drugs for metastatic triple-negative breast cancer (TNBC). IMMU-132 is a combination of two different molecules: an antibody that targets certain types of cancer and delivers a chemotherapy drug that can kill cancer cells. This study looks at whether IMMU-132 is safe and effective for treating metastatic TNBC. (4/16/19)

THIS INFORMATION HAS BEEN UPDATED on 04/27/20:  Based on the results from the study reviewed in this XRAY, the U.S. Food and Drug Administration (FDA) has approved sacituzumab govitecan-hizy (Trodelvy), as a treatment for people with metastatic triple-negative breast cancer who have received at least two prior therapies for metastatic disease. 

Read More
Smart drug shows promising results for treatment of metastatic triple-negative breast cancer

Relevance: Medium-High

pointerRelevance

Research Timeline: Post Approval

pointerResearch Timeline

Guideline : Breast surgeons recommend genetic testing for all breast cancer patients

Most relevant for: Anyone diagnosed with breast cancer

Summary: 

The American Society of Breast Surgeons published statement on genetic testing for hereditary breast cancer on February 10, 2019. It includes recommendations about who should be tested. Among these is the recommendation that all breast cancer patients get genetic testing, as well as women who do not have breast cancer but fit the National Comprehensive Cancer Network (NCCN) guidelines. (3/25/19)

Read More
Breast surgeons recommend genetic testing for all breast cancer patients

Relevance: High

pointerRelevance

Strength of Science: Medium-High

pointerStrength of Science

Research Timeline: Post Approval

pointerResearch Timeline
View Related Clinical Trials

Study : Gaps in information about breast cancer risk and prevention impact African American women

Most relevant for: African American women who are at high risk for breast cancer

A study showed that African American women with increased breast cancer risk experienced greater burdens in obtaining information at each step compared to white women. Racial differences in preventive choices correlated with differences in information and provider access. (3/14/19)

Read More
Gaps in information about breast cancer risk and prevention impact African American women

Relevance: Medium-High

pointerRelevance

Strength of Science: Medium-High

pointerStrength of Science

Research Timeline: Post Approval

pointerResearch Timeline

Study : Prevalence of BRCA founder mutations in Bahamian women

Most relevant for: Bahamanian women

Summary:

The Bahamas has the highest known frequency of BRCA mutations among people diagnosed with breast cancer. This study reviewed whether population-based BRCA testing (testing everyone regardless of family or personal history of cancer) would be an effective approach for finding mutation carriers in the Bahamas. (3/4/19)

Read More
Prevalence of BRCA founder mutations in Bahamian women

Relevance: Medium-Low

pointerRelevance

Strength of Science: Low

pointerStrength of Science

Research Timeline: Post Approval

pointerResearch Timeline

Study : Breast cancer implant study suggests links with illness but has serious flaws

Most relevant for: Women with or considering breast implant reconstruction

An article in the Annals of Surgery, researchers conclude that their work supports an association between silicone breast implants and a range of conditions. This journal article was accompanied by two editorials in which experts voiced their disagreement with the way the analysis was performed and the conclusions of the authors. (2/21/19)

Read More
Breast cancer implant study suggests links with illness but has serious flaws